A Validated, Stability-Indicating HPTLC Method for Analysis of Doxofylline

被引:8
|
作者
Patre, Narendra G. [1 ]
Sathiyanarayanan, L. [1 ]
Mahadik, Mahadeo V. [1 ]
Dhaneshwar, Sunil R. [1 ]
机构
[1] Bharati Vidyapeeth Univ, Dept Pharmaceut Chem, Poona Coll Pharm, Ctr Adv Pharmaceut Res, Pune 411038, Maharashtra, India
关键词
Degradation; Doxofylline; HPTLC; Stability-indicating; Validation; HPLC METHOD; DOXOPHYLLINE; EXTRACTION;
D O I
10.1556/JPC.22.2009.5.5
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, sensitive, selective, precise, and stability-indicating high-performance thin-layer chromatographic method for analysis of doxofylline as the bulk drug and in formulations has been developed and validated. The method used aluminum plates coated with silica gel 60 F-254 as stationary phase and toluene-m ethanol 8:2 (v/v) as mobile phase, followed by densitometric measurement at 254 nm. The R-F value of doxofylline was 4.3. The drug was subjected to acidic, alkaline, oxidative, and photolytic stress to establish a validated stability-indicating HPTLC method. The method was validated in accordance with ICH guidelines; there was no chromatographic interference from tablet excipients. The drug was found to be stable under wet and dry heat conditions. Because the method could effectively separate the drug from its degradation products it can be regarded as stability-indicating.
引用
收藏
页码:345 / 348
页数:4
相关论文
共 50 条
  • [21] Stability-Indicating HPTLC Method for Analysis of Tolterodine in the Bulk Drug
    Akanksha Mishra
    Vasantharaju Surenehalli Gowdra
    Karthik Arumugam
    Syed Sajjad Hussen
    Krishnamoorthy Bhat
    Nayanabhirama Udupa
    JPC – Journal of Planar Chromatography – Modern TLC, 2011, 24 : 150 - 153
  • [22] A Validated Stability-Indicating HPTLC Method for the Estimation of Gemcitabine HCI in its Dosage Form
    Borisagar, Sanjay L.
    Patel, Harsha U.
    Patel, Chhaganbhai N.
    JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2012, 25 (01) : 77 - 80
  • [23] Stability-Indicating HPTLC Method for Analysis of Torsemide in Pharmaceutical Preparations
    Kakde, R.
    Chaudhary, N.
    Barsagade, A.
    Kale, D.
    ACTA CHROMATOGRAPHICA, 2011, 23 (01) : 145 - 155
  • [24] Development and validation of a stability-indicating HPTLC-Densitometric method for satranidazole
    Patel, M. B.
    Patel, K. M.
    Patel, G. S.
    Suhagia, B. N.
    Prajapati, A. M.
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2007, 30 (13-16) : 2459 - 2471
  • [25] A Validated Stability-Indicating HPTLC Method for the Estimation of Gemcitabine HCI in its Dosage Form
    Sanjay L. Borisagar
    Harsha U. Patel
    Chhaganbhai N. Patel
    JPC – Journal of Planar Chromatography – Modern TLC, 2012, 25 : 77 - 80
  • [26] Validated Stability-Indicating HPTLC Method for Cefixime and Azithromycin with Preparative Isolation, Identification, and Characterization of Degradation Products
    Gawande, V. T.
    Bothara, K. G.
    Satija, C. O.
    ACTA CHROMATOGRAPHICA, 2018, 30 (04) : 212 - 218
  • [27] Development and Validation of a Stability-Indicating HPTLC Method for Analysis of Rupatadine Fumarate in the Bulk Drug and Tablet Dosage Form
    Shirkhedkar, A. A.
    Thorve, R. R.
    Fursule, R. A.
    Surana, S. J.
    ACTA CHROMATOGRAPHICA, 2008, 20 (03) : 423 - 437
  • [28] Application of a Stability-Indicating HPTLC Method for Quantitative Analysis of Amtolmetin Guacil in a Pharmaceutical Dosage Form
    Bhusari, V. K.
    Mahadik, M. V.
    Dhaneshwar, S. R.
    ACTA CHROMATOGRAPHICA, 2009, 21 (02) : 299 - 317
  • [29] Development and Validation of a Stability-Indicating HPTLC Assay Method for Idebenone
    Rathi, A. A.
    Dhamecha, D. L.
    Dehghan, M. H. G.
    Saifee, M.
    Wakte, P. S.
    Shelke, S. D.
    Dongre, S. H.
    ACTA CHROMATOGRAPHICA, 2011, 23 (02) : 281 - 294
  • [30] Validated Stability Indicating HPTLC Method Development for Rivaroxaban in Tablets
    Nimje, Hemlata
    Magar, Mayuri
    Kamble, Pranita
    Rongali, Niharika
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (03) : 918 - 924